FinTrust Investment Advisory Services’s Pfizer PFE Stock Holding History

FinTrust Investment Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$935K	Buy	27,780 +9	+0%	+$309	0.86%	22
2017 Q4	$954K	Buy	27,771 +327	+1%	+$11.2K	0.84%	23
2017 Q3	$930K	Buy	+27,444	New	+$882K	0.89%	21

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FinTrust Investment Advisory Services's PFE Position: Q1 2018 in Review

FinTrust Investment Advisory Services increased its Pfizer (PFE) stake by 0.03% in Q1 2018, buying an estimated $309 and bringing the position to 27,780 shares worth $935K. The position accounts for 0.86% of the portfolio, ranked #22.

FinTrust Investment Advisory Services first reported a position in PFE in Q3 2017 and has held it in 3 quarters since. The position peaked at $954K in Q4 2017. 2,231 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

FinTrust Investment Advisory Services held 27,780 shares of Pfizer worth $935K as of Q1 2018.
FinTrust Investment Advisory Services bought 9 Pfizer shares in Q1 2018, an estimated $309.
Pfizer made up 0.86% of FinTrust Investment Advisory Services's portfolio in Q1 2018, its #22 holding.
FinTrust Investment Advisory Services first reported a position in Pfizer in Q3 2017 and has held it in 3 quarters since.
FinTrust Investment Advisory Services's Pfizer position peaked at $954K in Q4 2017.
2,231 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on FinTrust Investment Advisory Services's 13F filing for Q1 2018, filed 20 Apr 2018.